Changing Therapies in Type 2 Diabetes
Seiten
2002
CRC Press (Verlag)
978-1-84184-111-3 (ISBN)
CRC Press (Verlag)
978-1-84184-111-3 (ISBN)
This monograph summarizes the proceedings of the VII International Barts Symposium held 20 April 2001 in London, United Kingdom. Chapters address new developments in the administration of insulin, including oral preparations and long-acting insulin analogue.
The Seventh International Barts Symposium was held on April 20, 2001, in London. This monograph summarizes the proceedings of that conference, which shed new light on therapies used for Type 2 diabetes. The contributors are world-renowned experts in the field, and they provide incisive commentary in their respective specialties. Chapters address new developments in the administration of insulin, including oral preparations and long-acting insulin analogue. Breakthroughs in the understanding of the pathogenesis of type 2 diabetes are also discussed, along with the future of the glitazones in management. Changing Therapies for Type 2 Diabetes is essential for diabetologists, general practitioners, cardiologists, geriatricians, and specialists in internal medicine.
The Seventh International Barts Symposium was held on April 20, 2001, in London. This monograph summarizes the proceedings of that conference, which shed new light on therapies used for Type 2 diabetes. The contributors are world-renowned experts in the field, and they provide incisive commentary in their respective specialties. Chapters address new developments in the administration of insulin, including oral preparations and long-acting insulin analogue. Breakthroughs in the understanding of the pathogenesis of type 2 diabetes are also discussed, along with the future of the glitazones in management. Changing Therapies for Type 2 Diabetes is essential for diabetologists, general practitioners, cardiologists, geriatricians, and specialists in internal medicine.
R.D.G. Leslie, Paolo Pozzilli
The heterogeneity of type 2 diabetes. Preventing cardiovascular disease in diabetes. Insulin by mouth (buccalor inhaled). Long-acting insulin analogue. Potential of glitazones in diabetes. Clinical value of glitazones.
| Erscheint lt. Verlag | 25.4.2002 |
|---|---|
| Verlagsort | London |
| Sprache | englisch |
| Maße | 140 x 210 mm |
| Gewicht | 263 g |
| Themenwelt | Medizin / Pharmazie ► Allgemeines / Lexika |
| Medizinische Fachgebiete ► Innere Medizin ► Diabetologie | |
| ISBN-10 | 1-84184-111-0 / 1841841110 |
| ISBN-13 | 978-1-84184-111-3 / 9781841841113 |
| Zustand | Neuware |
| Haben Sie eine Frage zum Produkt? |
Mehr entdecken
aus dem Bereich
aus dem Bereich
Buch | Softcover (2022)
Urban & Fischer in Elsevier (Verlag)
CHF 75,60
Vol. 1 & 2
Buch | Hardcover (2022)
McGraw-Hill Companies (Verlag)
CHF 284,90
